Advances in basic research, clinical diagnosis and treatment of pancreatic cancer in 2020
Pancreatic cancer is one of the more dismal gastrointestinal tumors due to the obscure symptoms in the early stage of disease, rapid progression and insensitivity to chemotherapy. The 5-year survival rate is only approximately 9% for patients with pancreatic cancer. In the recent years, with the cha...
Main Author: | TANG Rong, SHI Si, ZHANG Bo, XU Jin, WANG Wei, YU Xianjun |
---|---|
Format: | Article |
Language: | English |
Published: |
Editorial Office of China Oncology
2021-01-01
|
Series: | Zhongguo aizheng zazhi |
Subjects: | |
Online Access: | http://www.china-oncology.com/fileup/1007-3639/PDF/20210101.pdf |
Similar Items
-
Advances in basic research, clinical diagnosis and treatment of pancreatic cancer in 2023
by: LI Tianjiao, YE Longyun, JIN Kaizhou, WU Weiding, YU Xianjun
Published: (2024-01-01) -
Advances in basic research, clinical diagnosis and treatment of pancreatic cancer in 2021
by: ZHU Xinzhe, LI Hao, XU Huaxiang, LUO Guopei, YU Xianjun
Published: (2022-01-01) -
New progress in basic research, clinical diagnosis and treatment of pancreatic cancer in 2022
by: WANG Xu, CHENG He, LIU Chen, YU Xianjun
Published: (2023-01-01) -
Advances in basic research, clinical diagnosis and treatment of prostate cancer in 2022
by: PAN Jian, ZHU Yao, DAI Bo, YE Dingwei
Published: (2023-03-01) -
Advances in basic research, clinical diagnosis and treatment of bladder cancer in 2022
by: ZHENG Shengfeng, ZHU Yiping, YE Dingwei
Published: (2023-03-01)